Esperion Therapeutics Inc Strategic Asset Allocation Index
Esperion Therapeutics Inc strategic asset allocation index. Esperion Therapeutics Inc (ESPR) has a Strategic Asset Allocation Index of 15.7% as of September 2020. Strategic assets (PP&E of $1.41 Million plus long-term investments of $-) total $1.41 Million, measured against net assets of $8.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Esperion Therapeutics Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Esperion Therapeutics Inc (2013–2019)
Strategic asset allocation index of Esperion Therapeutics Inc from 2013 to 2019. This chart shows how Esperion Therapeutics Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2013 to 2019. As of September 2020, the index stands at 15.7%, representing strategic assets of $1.41 Million against net assets of $8.96 Million USD. Check Esperion Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Esperion Therapeutics Inc Strategic Asset Allocation Index by Year (2013–2019)
Esperion Therapeutics Inc strategic asset allocation index by year from 2013 to 2019. The table below presents the year-by-year Strategic Asset Allocation Index for Esperion Therapeutics Inc from 2013 to 2019, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ESPR company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 179.4% | $35.80 Million | $1.15 Million | $34.65 Million | $19.95 Million | ▲ +178.5 pp |
| 2018 | 1.0% | $763.00K | $520.00K | $243.00K | $79.12 Million | ▼ -29.2 pp |
| 2017 | 30.2% | $73.86 Million | $435.00K | $73.42 Million | $244.69 Million | ▲ +16.4 pp |
| 2016 | 13.8% | $31.58 Million | $674.00K | $30.91 Million | $228.60 Million | ▼ -14.4 pp |
| 2015 | 28.2% | $81.12 Million | $807.00K | $80.31 Million | $287.26 Million | ▲ +0.9 pp |
| 2014 | 27.3% | $36.52 Million | $780.00K | $35.74 Million | $133.55 Million | ▲ +3.6 pp |
| 2013 | 23.8% | $17.62 Million | $80.81K | $17.54 Million | $74.09 Million | — |